Forskning ved Københavns Universitet - Københavns Universitet

Forside

STXBP1 encephalopathy

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

  • Hannah Stamberger
  • Marina Nikanorova
  • Marjolein H. Willemsen
  • Patrizia Accorsi
  • Marco Angriman
  • Hartmut Baier
  • Ira Benkel-Herrenbrueck
  • Valérie Benoit
  • Mauro Budetta
  • Almuth Caliebe
  • Gaetano Cantalupo
  • Giuseppe Capovilla
  • Gianluca Casara
  • Carolina Courage
  • Marie Deprez
  • Anne Destrée
  • Robertino Dilena
  • Corrie E. Erasmus
  • Madeleine Fannemel
  • Roar Fjær
  • Og 37 flere
  • Lucio Giordano
  • Katherine L Helbig
  • Henrike O. Heyne
  • Joerg Klepper
  • Gerhard J. Kluger
  • Damien Lederer
  • Monica Lodi
  • Oliver Maier
  • Andreas Merkenschlager
  • Nina Michelberger
  • Carlo Minetti
  • Hiltrud Muhle
  • Judith Phalin
  • Keri Ramsey
  • Antonino Romeo
  • Jens Schallner
  • Ina Schanze
  • Marwan Shinawi
  • Kristel Sleegers
  • Katalin Sterbova
  • Steffen Syrbe
  • Monica Traverso
  • Andreas Tzschach
  • Peter Uldall
  • Rudy Van Coster
  • Helene Verhelst
  • Maurizio Viri
  • Susan Winter
  • Markus Wolff
  • Martin Zenker
  • Leonardo Zoccante
  • Peter De Jonghe
  • Ingo Helbig
  • Pasquale Striano
  • Johannes R. Lemke
  • Rikke S Møller
  • Sarah Weckhuysen

Objective: To give a comprehensive overview of the phenotypic and genetic spectrum of STXBP1 encephalopathy (STXBP1-E) by systematically reviewing newly diagnosed and previously reported patients. Methods: We recruited newly diagnosed patients with STXBP1 mutations through an international network of clinicians and geneticists. Furthermore, we performed a systematic literature search to review the phenotypes of all previously reported patients. Results: We describe the phenotypic features of 147 patients with STXBP1-E including 45 previously unreported patients with 33 novel STXBP1 mutations. All patients have intellectual disability (ID), which is mostly severe to profound (88%). Ninety-five percent of patients have epilepsy. While one-third of patients presented with Ohtahara syndrome (21%) or West syndrome (9.5%), the majority has a nonsyndromic early-onset epilepsy and encephalopathy (53%) with epileptic spasms or tonic seizures as main seizure type. We found no correlation between severity of seizures and severity of ID or between mutation type and seizure characteristics or cognitive outcome. Neurologic comorbidities including autistic features and movement disorders are frequent. We also report 2 previously unreported adult patients with prominent extrapyramidal features. Conclusion: De novo STXBP1 mutations are among the most frequent causes of epilepsy and encephalopathy. Most patients have severe to profound ID with little correlation among seizure onset, seizure severity, and the degree of ID. Accordingly, we hypothesize that seizure severity and ID present 2 independent dimensions of the STXBP1-E phenotype. STXBP1-E may be conceptualized as a complex neurodevelopmental disorder rather than a primary epileptic encephalopathy.

OriginalsprogEngelsk
TidsskriftNeurology
Vol/bind86
Udgave nummer10
Sider (fra-til)954-962
Antal sider9
ISSN0028-3878
DOI
StatusUdgivet - 8 mar. 2016

ID: 179218386